Genentech Actemra drug shows superiority over adalimumab
Actemra is the first humanized IL-6 receptor-inhibiting monoclonal antibody approved for the treatment of adult patients with moderately to severely active RA and for the treatment of active
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
Omkar Speciality manufactures speciality chemicals such as selenium compounds, iodine compounds, molybdenum compounds and pharma intermediates including potassium iodate, bismuth ammonium citrate, bromoform. The company has four units